Position in DNA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,297,565
+$1,297,565 QoQ
Shares Held
130,935
Ownership
0.194%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#40
of 183 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DNA Over Time
Shares Held
Position Value (USD)
Derivatives in DNA
reported options exposure · as of Jun 30, 2026CallValue
$1,073,253
CallShares
108,300
PutValue
$347,841
PutShares
35,100
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026CITADEL ADVISORS LLC holds $6,088,670,159 across 436 Biotechnology names. DNA ranks #216 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ONC |
BeOne Medicines Ltd.
|
1,425,517 | $406,229,578 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
3,760,028 | $280,046,885 | |
| 3 | INSM |
INSMED Inc
|
2,556,973 | $272,624,460 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
507,233 | $272,358,759 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
510,430 | $253,545,893 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,006,676 | $242,578,715 | |
| 7 | MANE |
Veradermics, Inc
|
1,877,775 | $230,853,658 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
5,576,261 | $197,343,876 |
All Filings in DNA
Export CSV
50 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $347,841 | 35,100 | Put | Defined | 2026-08-14 | |
| 2026-06-30 | $1,297,565 | 130,935 | Shares | Defined | 2026-08-14 | |
| 2026-06-30 | $1,073,253 | 108,300 | Call | Defined | 2026-08-14 | |
| 2026-03-31 | $326,729 | 53,300 | Put | Defined | 2026-05-15 | |
| 2026-03-31 | $217,002 | 35,400 | Call | Defined | 2026-05-15 | |
| 2025-12-31 | $595,245 | 71,630 | Put | Defined | 2026-02-17 | |
| 2025-12-31 | $1,138,470 | 137,000 | Call | Defined | 2026-02-17 | |
| 2025-09-30 | $652,280 | 44,738 | Put | Defined | 2025-11-14 | |
| 2025-09-30 | $2,979,393 | 204,348 | Call | Defined | 2025-11-14 | |
| 2025-06-30 | $133,852 | 11,898 | Put | Defined | 2025-08-14 | |
| 2025-06-30 | $5,005,170 | 444,904 | Call | Defined | 2025-08-14 | |
| 2025-06-30 | $113,782 | 10,114 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $393,835 | 69,094 | Put | Defined | 2025-05-15 | |
| 2025-03-31 | $543,289 | 95,314 | Call | Defined | 2025-05-15 | |
| 2024-12-31 | $1,276,285 | 129,968 | Put | Defined | 2025-02-14 | |
| 2024-12-31 | $1,391,837 | 141,735 | Shares | Defined | 2025-02-14 | |
| 2024-12-31 | $586,862 | 59,762 | Call | Defined | 2025-02-14 | |
| 2024-09-30 | $510,825 | 62,678 | Put | Defined | 2024-11-14 | |
| 2024-09-30 | $487,370 | 59,800 | Call | Defined | 2024-11-14 | |
| 2024-06-30 | $211,288 | 632,600 | Put | Defined | 2024-08-14 | |
| 2024-06-30 | $100,968 | 302,300 | Call | Defined | 2024-08-14 | |
| 2024-03-31 | $647,280 | 558,000 | Put | Defined | 2024-05-15 | |
| 2024-03-31 | $265,176 | 228,600 | Call | Defined | 2024-05-15 | |
| 2024-03-31 | $5,253,707 | 4,529,058 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $4,757,294 | 2,814,967 | Shares | Defined | 2024-02-14 | |
| 2023-12-31 | $945,048 | 559,200 | Put | Defined | 2024-02-14 | |
| 2023-12-31 | $498,896 | 295,205 | Call | Defined | 2024-02-14 | |
| 2023-09-30 DNABW | — | 13,015 | Shares | Defined | 2023-11-14 | |
| 2023-09-30 | $645,603 | 356,687 | Call | Defined | 2023-11-14 | |
| 2023-09-30 | $959,300 | 530,000 | Put | Defined | 2023-11-14 | |
| 2023-09-30 | $9,490,254 | 5,243,235 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 DNABW | — | 12,155 | Shares | Defined | 2023-08-14 | |
| 2023-06-30 | $1,921,930 | 1,033,296 | Shares | Defined | 2023-08-14 | |
| 2023-06-30 | $655,650 | 352,500 | Put | Defined | 2023-08-14 | |
| 2023-06-30 | $769,746 | 413,842 | Call | Defined | 2023-08-14 | |
| 2023-03-31 DNABW | — | 12,257 | Shares | Defined | 2023-05-15 | |
| 2023-03-31 | $506,120 | 380,542 | Call | Defined | 2023-05-15 | |
| 2023-03-31 | $1,221,489 | 918,413 | Shares | Defined | 2023-05-15 | |
| 2023-03-31 | $334,894 | 251,800 | Put | Defined | 2023-05-15 | |
| 2022-12-31 DNABW | — | 10,788 | Shares | Defined | 2023-02-14 | |
| 2022-12-31 | $1,636,594 | 968,399 | Call | Defined | 2023-02-14 | |
| 2022-12-31 | $207,439 | 122,745 | Shares | Defined | 2023-02-14 | |
| 2022-12-31 | $521,146 | 308,371 | Put | Defined | 2023-02-14 | |
| 2022-09-30 DNABW | — | 10,723 | Shares | Defined | 2022-11-14 | |
| 2022-09-30 | $429,792 | 137,754 | Shares | Defined | 2022-11-14 | |
| 2022-09-30 | $1,004,328 | 321,900 | Put | Defined | 2022-11-14 | |
| 2022-09-30 | $2,530,008 | 810,900 | Call | Defined | 2022-11-14 | |
| 2022-06-30 DNABW | — | 12,491 | Shares | Defined | 2022-08-15 | |
| 2022-06-30 | $872,270 | 366,500 | Put | Defined | 2022-08-15 | |
| 2022-06-30 | $1,124,312 | 472,400 | Call | Defined | 2022-08-15 | |
| No filing history on record for this holder in this stock. | ||||||